Loading...
Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL
Myeloablative autologous hematopoietic stem cell transplantation (HSCT) is a mainstay of therapy for relapsed intermediate-grade B-cell non-Hodgkin lymphoma (NHL); however, relapse rates are high. In phase 1 studies designed to improve long-term remission rates, we administered adoptive T-cell immun...
Na minha lista:
Udgivet i: | Blood |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
American Society of Hematology
2016
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4911862/ https://ncbi.nlm.nih.gov/pubmed/27118452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-12-686725 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|